Clindamycin Injection USP; 900 mg/6 mL (150 mg/mL). 6 mL Single-dose ADD-VANTAGE Vial, Rx Only, Manufactured for Alvogen, Inc., Pine Brook, NJ 07058, NDC 47781-464-69
Published July 12, 2017 · Recall initiated: June 16, 2017
Summary
FDA records drug Class II recall D-0941-2017, published July 12, 2017 and initiated June 16, 2017. Recalling firm: Alvogen, Inc; Status: Terminated; Reported quantity: 71,825 6 mL vials; Lot: Lots: 68-105-EV; Exp. 07/31/18, 68-106-EV; Exp. 07/31/18, and 73-157-EV; Exp. 12/31/18. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Lack of Assurance of Sterility
What to do
Voluntary: Firm initiated · Press Release
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Alvogen, Inc
- Distributor
- Nationwide
- Lot
- Lots: 68-105-EV; Exp. 07/31/18, 68-106-EV; Exp. 07/31/18, and 73-157-EV; Exp. 12/31/18
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDALevothyroxine Sodium Tablets, USP, Thyro-Tabs, 150mcg, 1000 Tablets, Rx only, Manufactured by: LLOYD, Inc.,January 21, 2026
- FDAFentanyl Transdermal System CII, 25mcg/h, packaged in a pouch, further packaged in 5-count carton, Rx only,February 26, 2025
- FDALevothyroxine Sodium Tablets, USP 112 mcg, 90 tablets per bottle, Rx Only, Manufactured by Lloyd Inc.,March 8, 2023
- FDABuprenorphine and Naloxone Sublingual Film 2mg/0.5mg, 30 pouches each containing 1 sublingual film,July 14, 2021
- FDAClindamycin Injection USP; 600 mg/4 mL (150 mg/mL). 4 mL Single-dose ADD-VANTAGE Vial, Rx Only, ManufacturedJuly 12, 2017
- FDAFludeoxyglucose F 18 Injection, 20mCi/mL to 200 mCi/mL at EOS, 30 mL Multiple-Dose Vial, Rx Only, ManufacturedJuly 12, 2017
Questions about this recall
Was Clindamycin Injection USP; 900 mg/6 mL (150 mg/mL). 6 mL Single-dose ADD-VANTAGE Vial, Rx Only, Manufactured for Alvogen, Inc., Pine Brook, NJ 07058, NDC 47781-464-69 recalled?
Yes. FDA published recall D-0941-2017 on July 12, 2017. Reported hazard: Lack of Assurance of Sterility
What should I do if I have this product?
Voluntary: Firm initiated · Press Release